234. COVID-19: Vaccines: Saturday, 12:15 - 1:30 p.m.
Poster Session: COVID-19: Vaccines
Ivan T. Lee, MD, PhD (he/him/his)
Director
Moderna, Inc.
Cambridge, Massachusetts, United States
Catherine A. Cosgrove, PhD
Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George’s University of London
London, England, United Kingdom
Patrick Moore, MRCGP
The Adam Practice and University Hospital Southampton NHS Foundation Trust
Southampton, England, United Kingdom
Marcin Bula, MBBS
University of Liverpool
Liverpool, England, United Kingdom
Philip Kalra, MD
Salford Royal Hospital and Northern Care Alliance NHS Foundation Trust
Salford, England, United Kingdom
Paul Dargan, MBBS
Guy’s & St Thomas’ NHS Foundation Trust and King’s College London
London, England, United Kingdom
Rebecca Clark, MBChB
Layton Medical Centre
Blackpool, England, United Kingdom
Marta Boffito, MD, PhD, FRCP
Chelsea and Westminster Hospital NHS Foundation Trust and Imperial College London
London, England, United Kingdom
Ray Sheridan, MRCP
Royal Devon University Hospital
Exeter, England, United Kingdom
Claire Bethune, MBBChir
University Hospitals Plymouth NHS Trust
Plymouth, England, United Kingdom
Fiona Burns, PhD
University College London
London, England, United Kingdom
Dinesh Saralaya, MD
National Institute for Health Research Patient Recruitment Centre and Bradford Teaching Hospitals NHS Foundation Trust
Bradford, England, United Kingdom
Rhiannon Nally, FRCGP
Wansford and Kings Cliffe Practice
Wansford, England, United Kingdom
Christopher J. A. Duncan, DPhil
Translational and Clinical Research Institute, Newcastle University and NIHR Newcastle Clinical Research Facility, The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, England, United Kingdom
David Chadwick, PhD
South Tees Hospitals NHS Foundation Trust, James Cook University Hospital
Middlesbrough, England, United Kingdom
Adrian Palfreeman, MBBS
University Hospitals of Leicester NHS Trust
Leicester, England, United Kingdom
Alberto San Francisco Ramos, FRCPath
Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George’s University of London
London, England, United Kingdom
Paul T. Heath, FRCPCH
Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George’s University of London
London, England, United Kingdom
Bethany Girard, Ph.D.
Moderna, Inc.
Cambridge, Massachusetts, United States
Kristen Sellers, PhD
Moderna, Inc.
Cambridge, Massachusetts, United States
Elizabeth de Windt, MPH
Moderna, Inc.
Cambridge, Massachusetts, United States
Andrea Sutherland, M.D., MPH
Moderna, Inc.
Cambridge, Massachusetts, United States
LaRee Tracy, PhD
Moderna, Inc.
Cambridge, Massachusetts, United States
Honghong Zhou, Ph.D.
Moderna, Inc.
Cambridge, Massachusetts, United States
Jacqueline Miller, MD
Moderna, Inc.
Cambridge, Massachusetts, United States
Frances Priddy, MD, MPH
Moderna, Inc.
Cambridge, Massachusetts, United States
Spyros Chalkias, MD (he/him/his)
Senior Medical Director
Moderna, Inc.
Cambridge, MA, United States
Rituparna Das, M.D.
Moderna, Inc.
Cambridge, Massachusetts, United States